Effects of yeast probiotic formulation on viability, revival and protection against infection withSalmonella entericassp.entericaserovar Typhimurium in mice
- 1 December 2009
- journal article
- research article
- Published by Oxford University Press (OUP) in Letters in Applied Microbiology
- Vol. 49 (6) , 738-744
Abstract
To compare the effects of five yeast probiotic formulations on viability, revival and washout kinetic in the digestive tract of mice, and the protection against an experimental infection with Salmonella enterica serovar Typhimurium. The number of viable cells in five commercial probiotic products codified as A, B, C and D (Saccharomyces boulardii- lyophilized) and E (Saccharomyces cerevisiae- aqueous suspension) was determined, as well as revival and washout kinetic in mouse intestine. Protective capacity was evaluated by survival rate and histopathology of liver and intestine of mice treated with each product and then challenged with Salm. Typhimurium. Product A contained the highest number of viable cells and, fed to mice, gave the highest counts of viable yeasts and the longest persistence in faeces. Probably as a consequence, the highest survival and protection of intestinal and hepatic tissues were observed when product A was used for mouse treatment. Product E showed low counts in the formulation and was not recovered from mouse intestine. Formulation (lyophilization or aqueous suspension) is an important factor for revival and survival of a probiotic product in vivo and consequently for its protective properties.Keywords
This publication has 15 references indexed in Scilit:
- Secreted bioactive factors fromBifidobacterium infantisenhance epithelial cell barrier functionAmerican Journal of Physiology-Gastrointestinal and Liver Physiology, 2008
- Review article: yeast as probiotics –Saccharomyces boulardiiAlimentary Pharmacology & Therapeutics, 2007
- Saccharomyces cerevisiae strain 905 reduces the translocation of Salmonella enterica serotype Typhimurium and stimulates the immune system in gnotobiotic and conventional miceJournal of Medical Microbiology, 2007
- Preservation of micro-organisms by drying; A reviewJournal of Microbiological Methods, 2006
- Saccharomyces boulardii produces a soluble anti-inflammatory factor that inhibits NF-κB-mediated IL-8 gene expressionBiochemical and Biophysical Research Communications, 2006
- Effect of Orally Administered Non‐Viable Lactobacillus Cells on Murine Humoral Immune ResponsesMicrobiology and Immunology, 2005
- Molecular and physiological comparisons betweenSaccharomyces cerevisiaeandSaccharomyces boulardiiCanadian Journal of Microbiology, 2004
- DNA from probiotic bacteria modulates murine and human epithelial and immune functionGastroenterology, 2004
- Enhanced pathogenicity of susceptible strains of the Bacteroides fragilis group subjected to low doses of metronidazoleMicrobes and Infection, 2003
- Simultaneous measurement of gastric emptying, small bowel residence and colonic filling of a solid meal by the use of the gamma camera.Gut, 1986